Beranda › Sklerosis Multipel › Kentucky

Uji klinis Sklerosis Multipel di Kentucky

3 studi untuk Sklerosis Multipel mencari peserta di lokasi di Kentucky.

Teks studi resmi (Bahasa Inggris)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

TG Therapeutics Investigational Trial Site, Lexington
TG Therapeutics Investigational Trial Site, Louisville

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of Kentucky/Markey Cancer Center, Lexington

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

University of Louisville, Norton Children's Research Institute, Louisville

Menerima pesertaFase 3

Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06408259

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.